Sign Up to like & get recommendations! 1
Published in 2019 at "Cancer Medicine"
DOI: 10.1002/cam4.2698
Abstract: The landscape of treatment for multiple myeloma (MM) has significantly changed over the last decade due to novel agents that have shown superiority in efficacy such as proteasome inhibitors (PIs) and immunomodulatory drugs (IMiDs) over… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Abdominal Radiology"
DOI: 10.1007/s00261-019-02175-0
Abstract: Purpose To provide an overview for radiologists of the systemic agents used in the treatment of advanced epithelial ovarian cancer (EOC) and their associated toxicities. Results EOC is a common gynecological malignancy, with the majority… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "Journal of Neuro-Oncology"
DOI: 10.1007/s11060-017-2442-8
Abstract: To investigate late toxicity among patients with newly-diagnosed brain metastases undergoing stereotactic radiosurgery (SRS) with concurrent systemic therapies with or without whole-brain radiation therapy (WBRT). Patients with newly-diagnosed brain metastasis who underwent SRS at a… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Current Treatment Options in Oncology"
DOI: 10.1007/s11864-019-0690-x
Abstract: Over the years, there have been significant advances in systemic treatments for metastatic pancreatic neuroendocrine tumors (panNETs). Despite these advancements, uncertainty remains regarding how to best sequence available therapies. For well-differentiated and metastatic panNETs that… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Clinical and Translational Oncology"
DOI: 10.1007/s12094-022-02803-0
Abstract: Central nervous system (CNS) dissemination is a severe complication in cancer and a leading cause of cancer-related mortality. Brain metastases (BMs) are the most common types of malignant intracranial tumors and are reported in approximately… read more here.
Sign Up to like & get recommendations! 0
Published in 2021 at "Advances in Therapy"
DOI: 10.1007/s12325-021-01800-z
Abstract: Treatment of hepatocellular carcinoma (HCC) recurrences following liver transplant (LT) is challenging. Most clinical trials of systemic therapies for advanced HCC excluded patients with any history of organ transplant. We aimed to assess the outcomes… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Dermatology and Therapy"
DOI: 10.1007/s13555-022-00721-1
Abstract: The comparative efficacy of targeted systemic therapies for moderate to severe atopic dermatitis (AD) has not been systematically assessed using recent phase 3 data. This network meta-analysis assesses the comparative efficacy of targeted systemic therapies… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique"
DOI: 10.1016/j.canrad.2019.08.007
Abstract: This article is a review of the literature that aims to clarify the place of systemic and locoregional treatments, with a focus on radiotherapy and surgery in the management of patients with oligometastatic kidney cancer.… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Oral oncology"
DOI: 10.1016/j.oraloncology.2019.104459
Abstract: Contrary to the impression that non-melanoma skin cancer is a banal and relatively trivial malignancy it causes about 1% of all cancer deaths. Cutaneous Squamous Cell carcinoma (CuSCC) make up a significant part of these… read more here.
Sign Up to like & get recommendations! 0
Published in 2020 at "Surgical pathology clinics"
DOI: 10.1016/j.path.2020.01.004
Abstract: Administration of systemic antineoplastic agents can result in adverse neurologic events. We describe the clinicopathologic features and putative mechanisms underlying iatrogenic neuropathology of the central nervous system secondary to chimeric antigen receptor (CAR) T-cell therapy… read more here.
Sign Up to like & get recommendations! 2
Published in 2022 at "Expert Review of Anticancer Therapy"
DOI: 10.1080/14737140.2022.2065987
Abstract: ABSTRACT Introduction Nonmelanoma skin cancers (NMSC) as a group exceed the incidence of all other malignancies combined. NMSC includes basal cell carcinoma, squamous cell carcinoma, and Merkel cell carcinoma. As the incidence continues to rise,… read more here.